Aspire Biopharma Holdings Inc
powerupacq.comWhat Do They Do?
Develops sublingual drug and supplement products, including aspirin and caffeine supplements, and sells caffeine products to consumers.
10-K for FY2025, filed Mar 30, 2026
Who Are Their Customers?
Customers order pharmaceutical products directly through Aspire’s website. For approved products, Aspire plans U.S. sales through a focused sales force and overseas distribution through third parties.
10-K for FY2025, filed Mar 30, 2026(1) Identify the contracts or agreements with a customer: The Company sells pharmaceutical products directly to customers from its website.…View ↗
We have not yet established a sales, marketing or product distribution infrastructure for our aspirin products because our lead product…View ↗
Subject to receiving marketing approvals, we expect to commence commercialization activities by building a focused sales and marketing…View ↗
How Are They Changing?
-
Aug 10, 2026
Acquired Dura Control Systems, an automotive and industrial controls supplier
DCS became a wholly owned subsidiary, adding automotive and industrial control systems to the portfolio.
Sources
8-K, filed Aug 10, 2026
Pursuant to the Closing Agreement, the Closing Documents were automatically released from escrow without any further action, and the…View ↗
Business focus
The business went from seeking a business combination in interactive media, digital media, gaming and entertainment to developing sublingual drug and nutraceutical products.
10-K for FY2022, filed Mar 21, 2023 10-K for FY2025, filed Mar 30, 2026
Loading...
